EP1040837A3
(en)
*
|
1999-02-26 |
2002-01-02 |
Erasmus Universiteit Rotterdam |
Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
|
AU767526B2
(en)
|
1999-04-26 |
2003-11-13 |
Gmp Vision Solutions, Inc. |
Trabeculotomy device and method for treating glaucoma
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US20050119737A1
(en)
*
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
AR030345A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes relacionados con angiogenesis
|
AR030346A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
|
US7181287B2
(en)
*
|
2001-02-13 |
2007-02-20 |
Second Sight Medical Products, Inc. |
Implantable drug delivery device
|
WO2002078681A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Alcon, Inc. |
Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
EP1977724A1
(en)
|
2001-04-07 |
2008-10-08 |
Glaukos Corporation |
System for treating ocular disorders
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
JP4261343B2
(ja)
|
2001-07-23 |
2009-04-30 |
アルコン,インコーポレイティド |
眼薬投与装置
|
WO2003009784A1
(en)
*
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
ES2393101T3
(es)
*
|
2001-08-29 |
2012-12-18 |
Ricardo A. P. De Carvalho |
Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
RU2322233C2
(ru)
*
|
2002-03-11 |
2008-04-20 |
Алькон, Инк. |
Имплантируемая система для доставки лекарственных средств
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
BR0309747A
(pt)
*
|
2002-05-03 |
2005-04-26 |
Alcon Inc |
Método para o tratamento de distúrbios vasculares mediados pelo fator de crescimento vascular endotelial
|
AU2003281817A1
(en)
*
|
2002-08-05 |
2004-02-23 |
Alcon, Inc. |
Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
JP2006507368A
(ja)
*
|
2002-09-29 |
2006-03-02 |
サーモディックス,インコーポレイティド |
ステロイド含有治療剤の網膜下投与方法;脈絡膜及び網膜に薬力学作用を局在化するための方法;並びに網膜疾患の治療及び/又は予防のための関連する方法
|
US20030187072A1
(en)
*
|
2003-02-14 |
2003-10-02 |
Kapin Michael A. |
Method of treating angiogenesis-related disorders
|
RU2005129276A
(ru)
*
|
2003-02-20 |
2006-01-27 |
Алькон, Инк. (Ch) |
Применение стероидов для лечения субъектов, страдающих заболеванием глаз
|
JP2006518383A
(ja)
*
|
2003-02-20 |
2006-08-10 |
アルコン,インコーポレイテッド |
病的な眼の新脈管形成を処置するための糖質コルチコイド処方物
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
CA2527121A1
(en)
*
|
2003-06-13 |
2004-12-29 |
Alcon, Inc. |
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
|
EP1635842A4
(en)
*
|
2003-06-20 |
2007-04-04 |
Alcon Inc |
TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS
|
MXPA05011517A
(es)
*
|
2003-07-10 |
2005-12-12 |
Alcon Inc |
Dispositivo para el suministro de medicamentos oftalmicos.
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
CA2536454C
(en)
*
|
2003-08-26 |
2013-03-26 |
Vista Scientific |
Ocular drug delivery device
|
CA2539324A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US7276050B2
(en)
*
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
US9549895B2
(en)
*
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
WO2006014484A2
(en)
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
US7722669B2
(en)
*
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
US8637070B2
(en)
|
2005-02-09 |
2014-01-28 |
Santen Pharmaceutical Co., Ltd. |
Rapamycin formulations and methods of their use
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
WO2006102378A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
EP1868661A1
(en)
|
2005-04-08 |
2007-12-26 |
SurModics, Inc. |
Sustained release implants for subretinal delivery
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
KR20080033463A
(ko)
|
2005-07-27 |
2008-04-16 |
유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. |
단백질 미스폴딩을 보정하는 작은 화합물 및 그의 용도
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
WO2007047626A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
PT1968594E
(pt)
|
2005-11-29 |
2010-11-18 |
Glaxosmithkline Llc |
Tratamento de distúrbios neovasculares oculares tais como degeneração macular, estrias angióides, uveite e edema macular
|
EP2001438A2
(en)
*
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
DE602007012417D1
(de)
|
2006-03-14 |
2011-03-24 |
Univ Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
WO2007130663A2
(en)
*
|
2006-05-04 |
2007-11-15 |
Herbert Kaufman |
Method, device, and system for delivery of therapeutic agents to the eye
|
US8506515B2
(en)
|
2006-11-10 |
2013-08-13 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
WO2008063639A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
ZA200903649B
(en)
*
|
2006-12-18 |
2010-08-25 |
Alcon Res Ltd |
Devices and methods for ophthalmic drug delivery
|
DE102007024642A1
(de)
|
2007-05-24 |
2008-11-27 |
Eyesense Ag |
Hydrogel-Implantat für Sensorik von Metaboliten am Auge
|
ES2425769T5
(es)
|
2007-12-20 |
2017-07-28 |
University Of Southern California |
Aparato para la administración de agentes terapéuticos
|
EP2266643B1
(en)
*
|
2008-01-03 |
2015-06-17 |
University Of Southern California |
Implantable drug-delivery devices, and apparatus and methods for refilling the devices
|
JP2011519695A
(ja)
*
|
2008-05-08 |
2011-07-14 |
リプレニッシュ パンプス, エルエルシー |
植設可能な薬物送達デバイスおよびそのデバイスを充填する装置および方法
|
US9849238B2
(en)
|
2008-05-08 |
2017-12-26 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
EP2320989B1
(en)
*
|
2008-05-08 |
2015-03-11 |
MiniPumps, LLC |
Implantable pumps and cannulas therefor
|
ES2534865T3
(es)
|
2008-05-08 |
2015-04-29 |
Minipumps, Llc |
Bombas de administración de fármacos
|
CA2723588A1
(en)
|
2008-05-12 |
2009-11-19 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated uses
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US8664182B2
(en)
|
2008-11-12 |
2014-03-04 |
Duke University |
Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
ES2921527T3
(es)
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Administración de fármaco en segmento anterior
|
IN2012DN00352A
(pt)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
JP5758388B2
(ja)
*
|
2009-08-18 |
2015-08-05 |
ミニパンプス, エルエルシー |
適応制御を有する電解質薬物送達ポンプ
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US20130137642A1
(en)
|
2010-04-23 |
2013-05-30 |
Demetrios Vavvas |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
JP2013526572A
(ja)
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
US8939948B2
(en)
|
2010-06-01 |
2015-01-27 |
Forsight Vision5, Inc. |
Ocular insert apparatus and methods
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
US8689439B2
(en)
|
2010-08-06 |
2014-04-08 |
Abbott Laboratories |
Method for forming a tube for use with a pump delivery system
|
US8377001B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Feeding set for a peristaltic pump system
|
US8377000B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Enteral feeding apparatus having a feeding set
|
US20120109054A1
(en)
*
|
2010-10-29 |
2012-05-03 |
Vista Scientific Llc |
Devices with an erodible surface for delivering at least one active agent to tissue over a prolonged period of time
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
EA032666B1
(ru)
|
2011-06-14 |
2019-06-28 |
Бикам Фармасьютикалз, Инк. |
Опсинсвязывающие лиганды и способы их применения
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
WO2013040079A1
(en)
|
2011-09-13 |
2013-03-21 |
Dose Medical Corporation |
Intraocular physiological sensor
|
WO2013040238A2
(en)
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
RS61758B1
(sr)
|
2011-09-16 |
2021-05-31 |
Forsight Vision4 Inc |
Aparati za razmenu tečnosti
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP2773341A2
(en)
|
2011-10-21 |
2014-09-10 |
Massachusetts Eye & Ear Infirmary |
Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
CN104884006B
(zh)
|
2012-10-26 |
2017-12-15 |
弗赛特影像5股份有限公司 |
用于持续释放药物到眼睛的眼科系统
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
EP2991621B1
(en)
*
|
2013-05-02 |
2020-12-09 |
Retina Foundation of the Southwest |
Two-layer ocular implant
|
CA2930015A1
(en)
|
2013-11-07 |
2015-05-14 |
Editas Medicine, Inc. |
Crispr-related methods and compositions with governing grnas
|
EP3089748A4
(en)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Treating ocular neovascularization
|
EP3114227B1
(en)
|
2014-03-05 |
2021-07-21 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
WO2015138510A1
(en)
|
2014-03-10 |
2015-09-17 |
Editas Medicine., Inc. |
Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
|
EP3148491B1
(en)
|
2014-05-29 |
2020-07-01 |
Glaukos Corporation |
Implants with controlled drug delivery features and manufacturing method for said implants
|
RU2695563C2
(ru)
|
2014-07-15 |
2019-07-24 |
Форсайт Вижн4, Инк. |
Способ и устройство для доставки глазного имплантата
|
CN107106551A
(zh)
|
2014-08-08 |
2017-08-29 |
弗赛特影像4股份有限公司 |
受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法
|
RU2708958C2
(ru)
|
2014-11-10 |
2019-12-12 |
Форсайт Вижн4, Инк. |
Расширяемые устройства доставки лекарственных средств и способы использования
|
EP3283004A4
(en)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
WO2016187426A1
(en)
|
2015-05-19 |
2016-11-24 |
Amorphex Therapeutics Llc |
A device that delivers a sustained low-dose of a myopia-suppressing drug
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017075475A1
(en)
|
2015-10-30 |
2017-05-04 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
MX2018006234A
(es)
|
2015-11-20 |
2018-08-14 |
Forsight Vision4 Inc |
Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
|
CN105997338B
(zh)
*
|
2016-03-09 |
2019-04-26 |
泰山医学院 |
经玻璃体纳米材料给药系统
|
MX2018012021A
(es)
|
2016-04-05 |
2019-01-24 |
Forsight Vision4 Inc |
Dispositivos de administracion de farmacos oculares implantables.
|
EP3442479A1
(en)
|
2016-04-20 |
2019-02-20 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
BR112019001887A2
(pt)
|
2016-08-02 |
2019-07-09 |
Editas Medicine Inc |
composições e métodos para o tratamento de doença associada a cep290
|
JP7100019B2
(ja)
|
2016-08-19 |
2022-07-12 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
選択的エストロゲン受容体モジュレーター(serm)は、光受容体の変性に対する保護を付与する
|
WO2018081504A1
(en)
|
2016-10-28 |
2018-05-03 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
WO2018204848A1
(en)
|
2017-05-05 |
2018-11-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Ocular applications of matrix bound vesicles (mbvs)
|
JP7221227B2
(ja)
|
2017-06-30 |
2023-02-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
発毛を調節するための組成物及び方法
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
WO2019169291A1
(en)
|
2018-03-02 |
2019-09-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of il-34 to treat retinal inflammation and neurodegeneration
|
DE112019001996T5
(de)
*
|
2018-04-18 |
2020-12-31 |
Nikon Corporation |
Bildverarbeitungsverfahren, Programm und Bildverarbeitungsvorrichtung
|
US20220079899A1
(en)
*
|
2019-01-14 |
2022-03-17 |
The Regents Of The University Of California |
Compositions and methods for treating ocular conditions
|
KR20210133993A
(ko)
|
2019-02-25 |
2021-11-08 |
에디타스 메디신, 인코포레이티드 |
Rho-연관 상염색체-우성 망막색소변성증(adrp)을 치료하기 위한 crispr/rna-가이드 뉴클레아제-관련 방법 및 조성물
|
EP4090381A1
(en)
|
2020-01-17 |
2022-11-23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
<smallcaps/>? ? ?crx-? ? ? ? ?gene therapy for treatment ofautosomal dominant retinopathies
|
WO2022006439A2
(en)
|
2020-07-02 |
2022-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compound embodiments for treating retinal degeneration and method embodiments of making and using the same
|
US20240207448A1
(en)
|
2021-04-16 |
2024-06-27 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
WO2024196814A1
(en)
|
2023-03-17 |
2024-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for treatment of age-related macular degeneration
|